L-2-Oxothiazolidine-4-carboxylic acid prevents endotoxin-induced cardiac dysfunction.

No abstract is available for this paper.

• Publication year

  1998

• Venue

  American Journal of Respiratory and Critical Care Medicine

• Publication date

  1998-10-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1164/AJRCCM.158.4.9702043PMID 9769268
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The systemic availability of oral glutathione

  2005cited by this paper
• Cytotoxic effects of acidic and sulphur containing amino acids on the infant mouse central nervous system

  2004cited by this paper
• Platelet-activating factor antagonism improves ventricular contractility in endotoxemia.

  1997cited by this paper
• Leukocytes and decreased left-ventricular contractility during endotoxemia in rabbits.

  1997cited by this paper
• Myocardial morphometric changes related to decreased contractility after endotoxin.

  1996cited by this paper
• Endotoxin-induced contractile dysfunction in guinea pig hearts is not mediated by nitric oxide.

  1995cited by this paper
• The role of nitric oxide in cardiac depression induced by interleukin‐1β and tumour necrosis factor‐α

  1995cited by this paper
• Prolonged leukocyte transit time in coronary microcirculation of endotoxemic pigs.

  1995cited by this paper
• The role of nitric oxide in cardiac depression induced by interleukin-1 beta and tumour necrosis factor-alpha.

  1995cited by this paper
• Anti-tumor necrosis factor-alpha prevents decreased ventricular contractility in endotoxemic pigs.

  1995cited by this paper
• Decrease in left ventricular contractility after tumor necrosis factor-alpha infusion in dogs.

  1994cited by this paper
• NADPH oxidase-derived reactive oxygen intermediates regulate tyrosine phosphorylation in human neutrophils.

  1994cited by this paper
• Development of a novel glutathione repleting agent, L-2-oxothiazolidine-4-carboxylic acid (Procysteine®)

  1994cited by this paper
• Cellular mechanisms of endotoxin-induced myocardial depression in rabbits.

  1993cited by this paper
• L-2-Oxothiazolidine-4-carboxylic acid as a cysteine precursor in acute experimental sepsis in rats: effects on tissue glutathione and cysteine levels

  1993cited by this paper
• Neutrophil induced oxidative injury of cardiac myocytes. A compartmented system requiring CD11b/CD18-ICAM-1 adherence.

  1992cited by this paper
• Nitric oxide production within cardiac myocytes reduces their contractility in endotoxemia.

  1992cited by this paper
• Negative inotropic effects of cytokines on the heart mediated by nitric oxide.

  1992influential reference
• Polymorphonuclear neutrophil contribution to induced tolerance to bacterial lipopolysaccharide.

  1991cited by this paper
• Studies using a canine model to investigate the cardiovascular abnormality of and potential therapies for septic shock.

  1990cited by this paper
• WEHI 164 subclone 13 assay for TNF: sensitivity, specificity, and reliability.

  1990cited by this paper
• The septic syndrome. Definition and clinical implications.

  1989cited by this paper
• Interleukin-2 administration causes reversible hemodynamic changes and left ventricular dysfunction similar to those seen in septic shock.

  1988cited by this paper
• A controlled clinical trial of high-dose methylprednisolone in the treatment of severe sepsis and septic shock.

  1987cited by this paper
• Comparative influence of load versus inotropic states on indexes of ventricular contractility: experimental and theoretical analysis based on pressure-volume relationships.

  1987cited by this paper
• Intracellular cysteine and glutathione delivery systems.

  1986cited by this paper
• Endotoxin and lung injury.

  1986cited by this paper
• The oxygen free radical system: a fundamental mechanism in the production of myocardial necrosis.

  1986cited by this paper
• Oxygen-derived free radicals in postischemic tissue injury.

  1985cited by this paper
• A circulating myocardial depressant substance in humans with septic shock. Septic shock patients with a reduced ejection fraction have a circulating factor that depresses in vitro myocardial cell performance.

  1985cited by this paper
• Profound but reversible myocardial depression in patients with septic shock.

  1984cited by this paper
• Glutathione.

  1983cited by this paper
• Selective modification of glutathione metabolism.

  1983cited by this paper
• Intracellular cysteine delivery system that protects against toxicity by promoting glutathione synthesis.

  1982cited by this paper
• Morphological changes in rat brain induced by L-cysteine injection in newborn animals.

  1981cited by this paper
• Stimulation of hepatic glutathione formation by administration of L-2-oxothiazolidine-4-carboxylate, a 5-oxo-L-prolinase substrate.

  1981influential reference

• Cardiac injury elicited by sub-chronic hookah smoke inhalation, and the alleviating effect of procysteine, 2-oxo-(4R)-4-thiazolidinecarboxylic acid, in BALB/c mice.

  2026cites this paper
• Protective Effects of L-2-Oxothiazolidine-4-Carboxylate during Isoproterenol-Induced Myocardial Infarction in Rats: In Vivo Study

  2022influential citation
• Cysteine Donor-Based Brain-Targeting Prodrug: Opportunities and Challenges

  2022cites this paper
• Sepsis-induced myocardial dysfunction

  2018cites this paper
• Treating oxidative stress in heart failure: past, present and future

  2018cites this paper
• The Ameliorative Effects of l-2-Oxothiazolidine-4-Carboxylate on Acetaminophen-Induced Hepatotoxicity in Mice

  2013cites this paper
• Protective effect of a cysteine prodrug and antioxidant, L-2-oxothiazolidine-4-carboxylate, against ethanol-induced gastric lesions in rats.

  2012cites this paper
• Pulmonary exposure to diesel exhaust particles promotes cerebral microvessel thrombosis: protective effect of a cysteine prodrug l-2-oxothiazolidine-4-carboxylic acid.

  2009cites this paper
• The biochemical basis of antioxidant therapy in critical illness

  2006cites this paper
• Albumin resuscitation increases cardiomyocyte contractility and decreases nitric oxide synthase II expression in rat endotoxemia*

  2003cites this paper
• Impaired energy metabolism during neonatal sepsis: the effects of glutamine

  2003cites this paper
• Oxothiazolidine Carboxylate Provides Protection against Hepatocellular Injury Seen after Porta Hepatis Occlusion (Pringle Maneuver) under Hypovolemic Conditions

  2003cites this paper
• Time course of nitric oxide, peroxynitrite, and antioxidants in the endotoxemic heart

  2002cites this paper
• L-2-Oxothiazolidine-4-Carboxylate: An Agent that Modulates Lipopolysaccharide-Induced Peritonitis in Rats

  2002cites this paper
• ICAM-1 and VCAM-1 mediate endotoxemic myocardial dysfunction independent of neutrophil accumulation.

  2002cites this paper
• Effect of Inflammatory Conditions on the Heart

  2000cites this paper
• Inhaled NO reduces leukocyte-endothelial cell interactions and myocardial dysfunction in endotoxemic rats.

  2000cites this paper